• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advances in the Pharmacological Treatment of Atrial Fibrillation.

作者信息

Burashnikov Alexander, Antzelevitch Charles

机构信息

Masonic Medical Research Laboratory, Utica, NY, USA.

出版信息

Curr Med Lit Cardiol. 2010 Jan 1;29(1):1-5.

PMID:21152111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2997698/
Abstract
摘要

相似文献

1
Advances in the Pharmacological Treatment of Atrial Fibrillation.心房颤动的药物治疗进展
Curr Med Lit Cardiol. 2010 Jan 1;29(1):1-5.
2
[Prevention and treatment of atrial fibrillation after cardiac surgery].
Arch Mal Coeur Vaiss. 2005 Sep;98(9):894-8.
3
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.心脏手术患者术后房颤的预防干预措施。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD003611. doi: 10.1002/14651858.CD003611.pub2.
4
[Atrial fibrillation: therapeutic options at the turn of the century.].[心房颤动：世纪之交的治疗选择。]
Laeknabladid. 2000 Dec;86(12):841-7.
5
Present treatment options for atrial fibrillation.心房颤动的现有治疗方案。
Postgrad Med J. 2003 Feb;79(928):67-73. doi: 10.1136/pmj.79.928.67.
6
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.心脏手术患者术后房颤的预防干预措施。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003611. doi: 10.1002/14651858.CD003611.pub3.
7
Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.ICU 患者新发心房颤动的药物和非药物治疗及结局：CAFE 范围综述和数据库分析。
Health Technol Assess. 2021 Nov;25(71):1-174. doi: 10.3310/hta25710.
8
Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study.慢性房颤患者药物或电复律后左心房及心耳的机械功能：一项多中心随机研究
Ital Heart J. 2000 Feb;1(2):128-36.
9
Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation: Value of neuroticism.阵发性心房颤动患者非药物干预的预测因素：神经质的价值。
Int J Cardiol. 2006 Jul 28;111(1):75-9. doi: 10.1016/j.ijcard.2005.07.018. Epub 2005 Oct 10.
10
Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score.急性症状性心房颤动成功药物复律的预测：心房颤动成功静脉复律（SIC-AF）评分
J Pers Med. 2022 Mar 30;12(4):544. doi: 10.3390/jpm12040544.

本文引用的文献

1
Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?心房颤动的心率控制与节律控制药物治疗：2008年我们处于什么阶段？
J Atr Fibrillation. 2008 May 16;1(1):21. doi: 10.4022/jafib.21. eCollection 2008 May-Jun.
2
New developments in atrial antiarrhythmic drug therapy.心房抗心律失常药物治疗的新进展。
Nat Rev Cardiol. 2010 Mar;7(3):139-48. doi: 10.1038/nrcardio.2009.245.
3
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.盐酸维纳卡兰治疗心脏手术后心房颤动的快速转复：一项随机、双盲、安慰剂对照试验。
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):652-9. doi: 10.1161/CIRCEP.109.870204.
4
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.ATHENA研究中卒中的分析：一项安慰剂对照、双盲、平行组试验，旨在评估每日两次服用400毫克决奈达隆预防心房颤动/心房扑动患者因任何原因导致的心血管住院或死亡的疗效。
Circulation. 2009 Sep 29;120(13):1174-80. doi: 10.1161/CIRCULATIONAHA.109.875252. Epub 2009 Sep 14.
5
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.决奈达隆与胺碘酮在维持心房颤动患者窦性心律方面的疗效比较
J Am Coll Cardiol. 2009 Sep 15;54(12):1089-95. doi: 10.1016/j.jacc.2009.04.085.
6
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.心房选择性钠通道阻滞作为一种治疗心房颤动的新策略。
J Electrocardiol. 2009 Nov-Dec;42(6):543-8. doi: 10.1016/j.jelectrocard.2009.07.007. Epub 2009 Aug 20.
7
New pharmacological strategies for the treatment of atrial fibrillation.治疗心房颤动的新药理学策略。
Ann Noninvasive Electrocardiol. 2009 Jul;14(3):290-300. doi: 10.1111/j.1542-474X.2009.00305.x.
8
Atrial-selective sodium channel block for the treatment of atrial fibrillation.用于治疗心房颤动的心房选择性钠通道阻滞剂
Expert Opin Emerg Drugs. 2009 Jun;14(2):233-49. doi: 10.1517/14728210902997939.
9
Novel approaches for pharmacological management of atrial fibrillation.心房颤动药物治疗的新方法。
Drugs. 2009;69(7):757-74. doi: 10.2165/00003495-200969070-00001.
10
Valsartan for prevention of recurrent atrial fibrillation.缬沙坦预防心房颤动复发
N Engl J Med. 2009 Apr 16;360(16):1606-17. doi: 10.1056/NEJMoa0805710.